ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CNTG Centogene NV

1.27
0.00 (0.0%)
Last Updated: 11:48:35
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Centogene NV CNTG NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.27 11:48:35
Open Price Low Price High Price Close Price Prev Close
1.24 1.24 1.27 1.27
more quote information »

Recent News

Date Time Source Heading
12/07/20239:28IHNWFeaturedAether Global Innovations Corp. and Idroneimages Ltd. To Hold An Online Networking Event Around Drone and UAV Beyond Visual Line of Site (BVLOS) Regulations on January 24, 2024
12/01/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/28/202306:30GLOBECENTOGENE and Lifera, a Public Investment Fund (PIF)..
11/28/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/14/202308:30GLOBECENTOGENE, University College London, and Global Team of..
11/03/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/27/202307:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202306:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/10/202306:30GLOBECENTOGENE Expands Multiomic Diagnostic Portfolio With..
10/06/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/11/202308:30GLOBECENTOGENE to Present at H.C. Wainwright 25th Annual Global..
9/07/202317:00GLOBECENTOGENE Reports First Half 2023 Financial Results
9/07/202317:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/01/202308:00GLOBECENTOGENE Announces Publication Establishing Lyso-Gb1 as a..
8/31/202316:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notification..
8/31/202316:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/18/202316:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/07/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in August
7/14/202306:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/14/202306:30GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
7/12/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/12/202307:30GLOBECENTOGENE Biodatabank Reveals Unique Genetic Variants in..
7/02/202305:00PRNUSLifera and CENTOGENE, Enter Strategic Collaboration -..
6/30/202316:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
6/30/202316:30GLOBECENTOGENE Announces Approval of All Resolutions Tabled at..
6/27/202307:30GLOBECENTOGENE and Lifera, a Biopharma Company Owned by the PIF,..
6/14/202316:30GLOBECENTOGENE Receives Nasdaq Notification Regarding Minimum..
5/16/202318:25GLOBECENTOGENE Reports Full Year 2022 Financial Results
5/05/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in May
4/28/202306:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice
4/26/202308:30GLOBECENTOGENE Accelerates Global Genetic Data Interpretation,..
4/14/202308:00GLOBECENTOGENE to Participate in Upcoming Conferences in April
4/12/202306:30GLOBECENTOGENE Launches NEW CentoGenome®, World’s Most..
4/11/202307:20DJNCentogene Extends Genetic Testing Partnership With Takeda
4/11/202306:30GLOBECENTOGENE Extends Strategic Partnership With Takeda to..
3/09/202306:30GLOBECENTOGENE Appoints Ian Rentsch as Chief Commercial Officer..
3/08/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in March
2/21/202306:30GLOBEIn the Lead-Up to Rare Disease Day, CENTOGENE Expands..
2/07/202308:00GLOBECENTOGENE Regains Compliance With Nasdaq Listing..
2/07/202306:30GLOBECENTOGENE to Participate in Upcoming Conferences in February..
1/10/202308:00BWTwist Bioscience and CENTOGENE Launch Three Panels to..
1/09/202308:30GLOBECENTOGENE and Denali Therapeutics Extend World’s Largest..
1/09/202308:00PRNUSPremier Research and CENTOGENE Launch Strategic Partnership..
12/28/202206:30GLOBECENTOGENE Announces Its Attendance at the 41st Annual J.P...
12/22/202216:00GLOBECENTOGENE Reports Second Quarter and First Half 2022..
12/16/202216:30GLOBECENTOGENE Receives Nasdaq Non-Compliance Notice

Your Recent History

Delayed Upgrade Clock